Researchers found that the risk substantially increased the longer people were prescribed a GLP-1 drug, particularly those containing semaglutide
Current guidelines generally reserve MBS for patients with Class IIIII obesity (BMI 40 or 35 with significant comorbid conditions), although recent recommendations recommend surgery for patients with BMI 3034.9 if T2DM is poorly controlled [33]
Kanellos I, Goulimaris I, Christoforidis E, Kelpis T, Betsis D
GDP by more than 10 percent due to lost workdays, disability, early mortality, and the burden of informal caregiving.[154] Given this landscape, innovations such as GLP-1s offer significant potential not only to alleviate individual disease burden but also to enhance economic productivity and growth
Although the trial was completed in May 2025, patient enrolment fell significantly short of the original target
In the new Turboslim preparation, the combination of alpha-lipoic acid, L-carnitine and B vitamins is as balanced as possible and contributes to the effective acceleration of metabolism